Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma

International Journal of Gynecological Cancer

Volumn 11, Issue 3, 2001, Pages 210-217

  Lopez Graniel, Carlos ^a   Reyes, M ^a   Chanona, G ^a   Gonzalez, A ^a   Robles, E ^a   Mohar, A ^a,b   Lopez Basave, H ^a   De La Garza, J G S ^a   Duenas Gonzalez A ^a,b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Cervical carcinoma; Hysterectomy; Induction chemotherapy

Indexed keywords

CISPLATIN; GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRANULOCYTOPENIA; HOSPITALIZATION; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MORBIDITY; OPERATION DURATION; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SURGICAL TECHNIQUE; TOXICITY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VEIN INJURY;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0034944924     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2001.01012.x     Document Type: Article

References (33)

1. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix
2. Pelvic radiation with concurrent chemotherapy compared with pelvic and paraaortic radiation for high-risk cervical cancer
3. A comparison of weekly cisplatin during radiation therapy versus irradiation alone each followed by adjuvant hysterectomy in bulky stage IB cervical carcinoma: A randomized trial of the Gynecology Oncology Group
4. Concurrent cisplatin-based chemoradiation improves progression-free survival in advanced cervical cancer: Results of a randomized gynecologic oncology group study
5. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes
6. Randomized phase III trial of neoadjuvant chemotherapy and radiotherapy vs radiotherapy in stage IIB III caracinoma of the cervix: A cooperative study of the French Oncology Centers
7. A randomized trial comparing platinum-based chemotherapy followed by radiotherapy vs. radiotherapy alone in patients with locally advanced cervical cancer
8. Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: A randomized study
9. A randomized trial of chemotherapy followed by pelvic radiotherapy in stage IIIB carcinoma of the cervix
10. A randomized trial of epirubicin and cisplatin chemotherapy followed by pelvic radiation in locally advanced cervical cancer
11. Evaluation of pelvic exenteration for advanced cancer of the cervix
12. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix
13. Comparative study of the patients with locally advanced stages I and II cervical cancer treated by radical surgery with and without perioperative adjuvant chemotherapy
14. Wertheim's hysterectomy after neoadjuvant carboplatin-based chemotherapy in patients with cervical cancer stage IIB and IIIB
15. Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: A well-tolerated alternative
16. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma
17. Reporting results of cancer treatment
18. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)
19. Non-parametric estimation from incomplete observations
20. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma
21. The prognostic significance of cell type and lesion size in patients with cervical cancer treated by radical surgery
22. Lymph node metastases from carcinoma of the cervix stages IB and IIA. Implications for prognosis and treatment
23. Modified type IV-V radical hysterectomy with systematic pelvic and aortic lymphadenectomy in the treatment of patients with stage III cervical carcinoma. Feasibility, technique, and clinical results
24. Lymph node metastases in carcinoma of the cervix uteri: Response to neoadjuvant chemotherapy and its impact on survival
25. Radical hysterectomy: A randomized study comparing two technique for resection of the cardinal ligament
26. Results of a phase II trial with neoadjuvant chemotherapy in carcinoma of the cervix uteri
27. Surgical treatment of cervical carcinoma stage IB1: Experience of the Instituto Nacional de Cancerología México
28. Long-term follow-up of the first randomized trial using neoadjuvant chemotherapy in stage Ib squamous carcinoma of the cervix: The final results
29. Randomized trial with neoadjuvant chemotherapy in stage IIIB squamous carcinoma of the cervix uteri: An unexpected therapeutic management
30. Neoadjuvant chemotherapy and radical surgery vs exclusive radiotherapy in locally advanced squamous cell cervical cancer. Results from the Italian Multicenter Randomized Trial
31. Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
32. Radiosensitization with carboplatin for patients with unresectable stage III non-small cell lung cancer: A phase III trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group